Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
Jui-Hsiang Hunga,1, Chiao-Feng Tengb,c,d,e,1, Hsu-chin Hungh, Yi-Lin Chenf, Pin-Jun Cheng, Chung-Liang Hof,g,h, Cheng-Hsiang Chuangi, Wenya Huangf,h,j,k,
Corresponding author
a Department of Biotechnology, Chia Nan University of Pharmacy & Science, Tainan, Taiwan
b Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
c Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
d Program for Cancer Biology and Drug Development, China Medical University, Taichung, Taiwan
e Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
f Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan
g Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
h Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan
i Department of Life Science, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu, Taiwan
j Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
k Center of Infectious Diseases and Signal Transduction, National Cheng Kung University, Tainan, Taiwan.
Ver másRead
2810
Timeswas read the article
412
Total PDF
2398
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 34 | 14 | 48 |
| 2025 11 | 244 | 101 | 345 |
| 2025 10 | 157 | 58 | 215 |
| 2025 9 | 150 | 25 | 175 |
| 2025 8 | 199 | 37 | 236 |
| 2025 7 | 196 | 33 | 229 |
| 2025 6 | 170 | 27 | 197 |
| 2025 5 | 195 | 11 | 206 |
| 2025 4 | 208 | 10 | 218 |
| 2025 3 | 152 | 13 | 165 |
| 2025 2 | 124 | 9 | 133 |
| 2025 1 | 188 | 16 | 204 |
| 2024 12 | 102 | 9 | 111 |
| 2024 11 | 89 | 6 | 95 |
| 2024 10 | 68 | 6 | 74 |
| 2024 9 | 68 | 17 | 85 |
| 2024 8 | 54 | 20 | 74 |
Show all
